NCT00394992 - Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Colorectal CancerLiver Metastases

Interventions

DRUG

oxaliplatin+capecitabine

postoperatively oxaliplatin 130 mg/m2 i.v. day 1 plus capecitabine 1000 mg/m2 b.i.d. on day 1-14, q3w

DRUG

Oxaliplatin+capecitabine+bevacizumab

postoperatively oxaliplatin 130 mg/m2 i.v. day 1 plus bevacizumab 7.5 mg/kg on day 1 plus capecitabine 1000 mg/m2 b.i.d. on day 1-14, q3w

Trial Locations (1)

Universitair Medisch Centrum Utrecht, Utrecht